Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 7141 AL 7155

[Pharmacological studies for the ameliorative effects of yokukansan on memory deficits and abnormal behavior in an animal model of dementia]

Iwasaki K, Takasaki K, Nogami A, Kubota K, Katsurabayashi S, Mishima K, Fujiwara M.

Nihon Yakurigaku Zasshi. 2012 Aug;140(2):66-70. doi: 10.1254/fpj.140.66.

Does vascular pathology contribute to Alzheimer changes?

Kalaria RN, Akinyemi R, Ihara M.

J Neurol Sci. 2012 Nov 15;322(1-2):141-7. doi: 10.1016/j.jns.2012.07.032. Epub 2012 Aug 11.

Can the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?

Richard F, Pasquier F.

J Alzheimers Dis. 2012;32(3):765-72. doi: 10.3233/JAD-2012-121012.

Cerebrovascular assessment for the risk prediction of Alzheimer's disease

Silvestrini M, Viticchi G, Altamura C, Luzzi S, Balucani C, Vernieri F.

J Alzheimers Dis. 2012;32(3):689-98. doi: 10.3233/JAD-2012-121240.

Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease

Daulatzai MA.

Neurochem Res. 2012 Dec;37(12):2627-58. doi: 10.1007/s11064-012-0854-6. Epub 2012 Aug 12.

The presence of behavioural and psychological symptoms and progression to dementia in the cognitively impaired older population

van der Linde RM, Stephan BC, Matthews FE, Brayne C, Savva GM; Medical Research Council Cognitive Function and Ageing Study.

Int J Geriatr Psychiatry. 2013 Jul;28(7):700-9. doi: 10.1002/gps.3873. Epub 2012 Aug 10.

Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease

Chhatwal JP, Sperling RA.

J Alzheimers Dis. 2012;31 Suppl 3(0 3):S155-67. doi: 10.3233/JAD-2012-120730.

[Clinical application of neuroimaging to alcohol-related dementia]

Matsui T, Sakurai H, Toyama T, Yoshimura A, Matsushita S, Higuchi S.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012 Jun;47(3):125-34.

Epidemiology of Alzheimer disease

Mayeux R, Stern Y.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a006239. doi: 10.1101/cshperspect.a006239.

Derivation and validation of a Short Form of the Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint

Haubois G, de Decker L, Annweiler C, Launay C, Allali G, Herrmann FR, Beauchet O.

Eur J Neurol. 2013 Mar;20(3):588-590. doi: 10.1111/j.1468-1331.2012.03830.x. Epub 2012 Aug 23.

Relationship between genetic risk factors and markers for Alzheimer's disease pathology

Elias-Sonnenschein LS, Bertram L, Visser PJ.

Biomark Med. 2012 Aug;6(4):477-95. doi: 10.2217/bmm.12.56.

Metabolic syndrome, mild cognitive impairment and Alzheimer's disease--the emerging role of systemic low-grade inflammation and adiposity

Misiak B, Leszek J, Kiejna A.

Brain Res Bull. 2012 Nov 1;89(3-4):144-9. doi: 10.1016/j.brainresbull.2012.08.003. Epub 2012 Aug 18.

The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging

Henderson TA.

CNS Spectr. 2012 Dec;17(4):176-206. doi: 10.1017/S1092852912000636. Epub 2012 Aug 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias